?1 prior program of chemotherapy for Superior breast cancer and throughout the complete trial, prior exposure to any FGFR inhibitor, main surgery or radiotherapy inside of 4 weeks before 1st dose of research cure and getting powerful inhibitors or inducers of CYP3A4 or CYP2D6. Any of the subsequent cardiac conditions precluded individuals entering: